Astral Systems
To add a bio or update company history, please click update information.
News from Astral Systems


Astral Systems
23 Jun 2026
Astral Systems unlocks £23m Series A led by Mercia Ventures to develop medical isotopes with multi-state fusion technology
Astral Systems is a Bristol-based deep-tech firm that invented and commercialised multi-state fusion technology, a new type of nuclear fusion. Its compact modular reactors produce medical radioisotopes and serve research, medical, and industrial customers facing fragile isotope supply chains.


Astral Systems
6 Feb 2025
Astral Systems raises £4.5m led by Speedinvest and Playfair to scale compact fusion reactors for medical isotopes
Astral Systems builds compact fusion reactors to produce medical isotopes locally, aiming to reduce shortages caused by ageing nuclear facilities.
Astral Systems
- Deep Tech
- Bristol, United Kingdom
- £27.5m
- astralsystems.com
- Update Information
More venture news
- 21 Jul 2026

Mach42Mach42 raises a £7m pre-Series A round led by IP Group to speed up analog circuit verification for semiconductor engineers
ExtensionDeep Tech - 21 Jul 2026

HALO X-ray TechnologiesHALO X-ray Technologies lands funding led by Agilent Technologies for X-ray diffraction screening of airport baggage
EquityDeep Tech - 16 Jul 2026

Silicon MicrogravitySilicon Microgravity secures £6m led by West Hill Capital for UK-built semiconductor sensors used in defence and space navigation
EquityDeep Tech